Amgen AMGN
NASDAQ AMGN
$433.73 -8.63 (-1.95%)
At close: Aug 20, 2026 · 4:00 PM EDT

Amgen (AMGN) Net Cash Flow (2009 - 2026)

Amgen (AMGN) posted quarterly Net Cash Flow of $2.9 billion for Q1 2026, up 191.97% year-over-year from $996.3 million in Q1 2025, and up 1020.57% quarter-over-quarter from -$316.0 million in Q4 2025.

Amgen (AMGN) Net Cash Flow (2009 - 2026) Analysis & Trends

Amgen's Net Cash Flow history runs 18 years deep, the most recent figure standing at $2.9 billion for Q1 2026.

  • In Q1 2026, Net Cash Flow rose 191.97% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 459.47% YoY), while the FY2025 annual figure was -$2.8 billion, down 376.38% from the prior year.
  • Net Cash Flow for Q1 2026 stood at $2.9 billion, up from -$316.0 million in the prior quarter.
  • The five-year high for Net Cash Flow was $23.9 billion in Q1 2023, with the low at -$23.8 billion in Q4 2023.
  • The 5-year median for Net Cash Flow is -$316.0 million (2025), against an average of $238.2 million.
  • Peak annual rise in Net Cash Flow reached 1737.99% in 2023, while the deepest fall reached 1170.53% in 2023.
  • Amgen's Net Cash Flow stood at -$1.9 billion in 2022, then slumped by 1170.53% to -$23.8 billion in 2023, then jumped by 112.45% to $3.0 billion in 2024, then slumped by 110.67% to -$316.0 million in 2025, then jumped by 1020.57% to $2.9 billion in 2026.
  • Business Quant data shows AMGN's Net Cash Flow at $2.9 billion in Q1 2026, -$316.0 million in Q4 2025, and $1.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn -1.27 Bn
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn -2.82 Bn
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn -6.80 Bn
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -4.43 Bn
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -722.00 Mn
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 2.68 Bn
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 27.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.95 Bn
Jun 30, 2026 1.95 Bn
Mar 31, 2026 2.91 Bn
Mar 31, 2026 2.91 Bn
Dec 31, 2025 -316.00 Mn
Dec 31, 2025 -316.00 Mn
Sep 30, 2025 1.42 Bn
Sep 30, 2025 1.42 Bn
Jun 30, 2025 -782.00 Mn
Jun 30, 2025 -782.00 Mn
Mar 31, 2025 -3.16 Bn
Mar 31, 2025 -3.16 Bn
Dec 31, 2024 2.96 Bn
Dec 31, 2024 2.96 Bn
Sep 30, 2024 -290.00 Mn
Sep 30, 2024 -290.00 Mn
Jun 30, 2024 -407.00 Mn
Jun 30, 2024 -407.00 Mn
Mar 31, 2024 -1.24 Bn
Mar 31, 2024 -1.24 Bn